Arstasis
Arstasis: Innovating cardiac device manufacturing for enhanced clinical procedures since 2006.
Founded
2004Arstasis: Innovating cardiac device manufacturing for enhanced clinical procedures since 2006.
Founded in 2006 and headquartered in Redwood City, California, Arstasis is a medical device manufacturer focused on providing innovative access devices for cardiologists and interventional radiologists. The company's core mission is to enhance clinical procedures and improve patient outcomes through its flagship product used in the Arstaotomy™ procedure. This novel technique aims to offer a more efficient and pleasant experience in the cath lab and post-procedure for both clinicians and patients.
Arstasis has garnered attention for its pioneering approach in the medical device industry, attracting notable investors and affiliations within the healthcare sector. The company's key achievements include the successful implementation of the Arstaotomy™ procedure, which has been well-received by medical professionals for its potential to streamline arterial access. Through its innovative solutions, Arstasis has made a significant impact on the field of interventional cardiology, contributing to advancements in patient care and procedural efficiency.
Companies similar to Arstasis include Ariste Medical, Protaryx Medical, Arbor Surgical Technologies and Ash Access Technology.
Arstasis was founded in 2004.
Arstasis' headquarters is located in Redwood City, CA, US.
Arstasis' most recent funding round was for $16.5M (USD) in November 2013.
As of Nov 18, 2013, Arstasis has disclosed funding of $95.4M (USD). Undisclosed round amounts are excluded.
Arstasis has 75 employees as of Feb 5, 2024.
Ash Access Technology
ashaccess.com
